3148
A. ARGADE ET AL.
REFERENCES
1. (a) Wang, Y.; Gloer, J. B.; Scott, J. A.; Malloch, D. Appenolides A-C: Three new antifun-
gal furanones from the coprophilous Fungus Podospora appendiculata. J. Nat. Prod.
1993, 56, 341; (b) Tamai, Y.; Torihara, M.; Kido, Y.; Yamahara, J.; Motizuki, M.; Ito,
M.; Katsuta, Y. Synthesis and antiulcer effects of 5-hydroxy-4-[2-substituted-(E)-
ethenyl]-2(5H)-furanone. Yakugaku Zasshi. 1993, 113, 655; (c) Baveja, J. K.; Li, G.;
Nordon, R. E.; Hume, E. B.; Kumar, N.; Willcox, M. D.; Poole-Warren, L. A. Biological
performance of a novel synthetic furanone-based antimicrobial. Biomaterials 2004,
25, 5013.
´
2. (a) Weber, V.; Coudert, P.; Rubat, C.; Duroux, E.; Vallee-Goyet, D.; Gardette, D.; Bria,
M.; Albuisson, E.; Leal, F.; Gramain, J. C.; Couquelet, J.; Madesclaire, M. Novel
4,5-diaryl-3-hydroxy-2(5H)-furanones as anti-oxidants and anti-inflammatory agents.
Bioorg Med Chem. 2002, 10, 1647; (b) Lattmann, E.; Ayuko, W. O.; Kinchinaton, D.;
Langley, C. A.; Singh, H.; Karimi, L.; Tisdale, M. J. Synthesis and evaluation of
5-arylated 2(5H)-furanones and 2-arylated pyridazin-3(2H)-ones as anti-cancer agents.
J. Pharm. Pharmacol. 2003, 55, 1259.
3. Sindhuramachandran, C. V.; Sreekumar, P. K.; Synthesis, characterization, and antibac-
terial evaluation of 2(5H)furanone Derivatives from highly functionalized mucobromic
acid. Int. J. Pharm. Pharm. Sci. 2011, 3, 225.
4. Sorbera, L. A.; Rabasseda, X.; Castaner, J. Rofecoxib. Drugs Fut. 1998, 23 (12), 1287.
5. (a) Prasit, P.; Wang, Z.; Brideau, C.; Chan, C. C.; Charlson, S.; Cromlish, W.; Ethier, D.;
Evans, J. F.; Ford-Hutchinson, A. W.; Gauthier, J. Y.; Gordon, R.; Guay, J.; Gresser, M.;
Kargman, S.; Kennedy, B.; Leblanc, Y.; Leger, S.; Mancini, J. O.; Neil, G. P.; Quellet, M.;
Percival, M. D.; Perrier, H.; Riendeau, D.; Rodger, I.; Tagari, P.; Therien, M.; Vikers, P.;
Wong, E.; Xu, L.; Young, R. N.; Zamboni, R.; Boyce, S.; Rupniak, N.; Forrest, M.;
Visco, D.; Patrick, D. The discovery of rofecoxib [MK 966, Vioxx, 4-(40-methylsulfonyl-
phenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor. Bioorg.
Med. Chem. Lett. 1999, 9, 1773; (b) Therien, M.; Gauthier, J. Y.; Leblanc, Y.; Leger,
´ ´
lene, P. P.; Wang, Z. Synthesis of rofecoxib (MK 0966, Vioxx1 4-(40-methyl-
S. P.; He
´
sulfonylphenyl)-3-phenyl-2(5H)-furanone), a selective and orally active inhibitor of
cyclooxygenase-2. Synthesis 2001, 1778; (c) Black, C.; Grimm, E.; Wang, Z.; Leger, S.
Diaryl-5-oxygenated 2-(5H)-furanones as COX-2 inhibitors. U.S. Patent 5691374, 1997.
6. (a) Yao, M.-N.; Deng, M.-Z. Facile approach to 4-substituted 2(5H)-furanones. J. Org.
Chem. 2000, 65, 5034; (b). Wu, J.; Zhu, Q.; Wang, L.; Fathi, R.; Yang, Z.
Palladium-catalyzed cross-coupling reactions of 4-tosyl-2-(5H)-furanone with boronic
acid: A facile and efficient route to generate 4-substited 2(5H)-furanones. J. Org. Chem.
2003, 68, 670; (c). Eabio, B.; Chiara, A.; Renzo, R. Synthesis of 4-alkyl-3-bromo-
2(5H)-furanones and unsymmetrically disubtituted 3,4-dialkyl-2(5H)-furanones by
palladium-catalysed cross-coupling reactions. Tetrahedron Lett. 2001, 42, 3851; (d)
Boukouvalas, J.; Lachance, N.; Ouellet, M.; Trudeau, M. Facile access to 4-aryl-2(5-
H)-furanones by Suzuki cross coupling: Efficient synthesis of rubrolides C and E. Tetra-
hedron Lett. 1998, 39, 7665; (e) Lee, G. C. M.; Garst, M. E. 2(5H)-Furanones substituted
in the 5 and=or in the 4 position, as anti-inflammatory agents. WO Patent 9116,055, 1991;
Chem. Abstr. 1992, 116, 59197m.
7. (a) Still, J. K. The Palladium-catalysed cross-coupling reaction of organoboron reagents.
Angew. Chem. Int. Ed. 1986, 25, 508; (b) Farina, V.; Krishnamurthy, V.; Scott, W. J. The
Stille reactions. Org. React. 1998, 50, 1; (c) Bellina, F.; Falchi, E.; Rossi, R. Regioselective
synthesis of cytotoxic 4-(1-alkynyl)-substituted 2-(5H)-furanones. Tetrahedron 2003, 59,
9091; (d) Bellina, F.; Anselmi, C.; Viel, S.; Maunina, L.; Rossi, R. Selective synthesis of
(Z)-4-aryl-5-[1-(aryl) methylidene]-3-bromo-2(5H)-furanones. Tetrahedron 2001, 57,